Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Creutzig, U; Dworzak, M; Zimmermann, M; Bourquin, J-P; Gruhn, B; Fleischhack, G; Graf, N; Klingebiel, T; Kremens, B; Lehrnbecher, T; von Neuhoff, C; von Stackelberg, A; Stray, J; Reinhardt, D (2015). Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML--results from Study AML-BFM 2004. Klinische Pädiatrie, 227(3):116-122.

Aalbers, A M; van der Velden, V H J; Yoshimi, A; Fischer, A; Noellke, P; Zwaan, C M; Baumann, I; Beverloo, H B; Dworzak, M; Hasle, H; Locatelli, F; De Moerloose, B; Göhring, G; Schmugge, M; Stary, J; Zecca, M; Langerak, A W; van Dongen, J J M; Pieters, R; Niemeyer, C M; van den Heuvel-Eibrink, M M (2014). The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS. Leukemia, 28(1):189-92.

Aalbers, A M; van den Heuvel-Eibrink, M M; Baumann, I; Beverloo, H B; Driessen, G J; Dworzak, M; Fischer, A; Göhring, G; Hasle, H; Locatelli, F; De Moerloose, B; Noellke, P; Schmugge, M; Stary, J; Yoshimi, A; Zecca, M; Zwaan, C M; van Dongen, J J M; Pieters, R; Niemeyer, C M; van der Velden, V H J; Langerak, A W (2014). T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS. Blood Cancer Journal, 4:e209.

Aalbers, A M; van den Heuvel-Eibrink, M M; de Haas, V; Te Marvelde, J G; de Jong, A X; van der Burg, M; Dworzak, M; Hasle, H; Locatelli, F; De Moerloose, B; Schmugge, M; Stary, J; Zecca, M; Zwaan, C M; van de Loosdrecht, A A; van Dongen, J J M; Niemeyer, C M; van der Velden, V H J (2013). Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood. Leukemia, 27(9):1923-1925.

Wlodarski, M W; Mötter, J; Gorr, T A; Olk-Batz, C; Hasle, H; Dworzak, M; Niemeyer, C M; Flotho, C (2011). Abnormal promoter DNA methylation in juvenile myelomonocytic leukemia is not caused by mutation in DNMT3A. Blood, 118(16):4490-4491.

Schrappe, M; Valsecchi, M G; Bartram, C R; Schrauder, A; Panzer-Grümayer, R; Möricke, A; Parasole, R; Zimmermann, M; Dworzak, M; Buldini, B; Reiter, A; Basso, G; Klingebiel, T; Messina, C; Ratei, R; Cazzaniga, G; Koehler, R; Locatelli, F; Schäfer, B W; Aricò, M; Welte, K; van Dongen, J J M; Gadner, H; Biondi, A; Conter, V (2011). Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood, 118(8):2077-2084.

Creutzig, U; Zimmermann, M; Dworzak, M; Urban, C; Henze, G; Kremens, B; Lakomek, M; Bourquin, J P; Stary, J; Reinhardt, D (2010). Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses. British Journal of Haematology, 149(3):399-409.

This list was generated on Sat Oct 21 10:25:45 2017 CEST.